Publications by authors named "Marina Cihova"

Claim this Profile
A
Aurora kinase A inhibition as a synthetic lethality strategy in ARID1A-mutated gastroenteropancreatic neuroendocrine carcinoma.
Maria Urbanova, Fabrice Viol, Laura Ruiz-Cañas, Efthymios Koniaris, Rihards Saksis, Marina Cihova

Cancer Lett· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment of a metastatic patient-derived xenograft model of breast carcinoma.
Martin Bohac, Andrea Cumova, Marina Cihova, Lenka Trnkova, Eva Sedlackova

Neoplasma· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Placental mesenchymal stem cells: A promising platform for advancing gene therapy in pancreatic ductal adenocarcinoma.
Verona Buocikova, Ursula Altanerova, Andrea Soltysova, Michal Andrezal, Dajana Vanova, Marina Cihova

Biomed Pharmacother· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic deregulation in breast cancer microenvironment: Implications for tumor progression and therapeutic strategies.
Lenka Trnkova, Verona Buocikova, Michal Mego, Andrea Cumova, Monika Burikova, Marina Cihova

Biomed Pharmacother· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival.
Maria Urbanova, Marina Cihova, Verona Buocikova, Jan Slopovsky, Peter Dubovan

Biomed Pharmacother· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The third dimension of tumor microenvironment-The importance of tumor stroma in 3D cancer models.
Jana Plava, Michaela Cehakova, Marcela Kuniakova, Lenka Trnkova, Marina Cihova

Exp Biol Med (Maywood)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue.
Jesús Frutos Díaz-Alejo, Simon April-Monn, Marina Cihova, Verona Buocikova, Jorge Villalón López

J Vis Exp· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liquid biopsy and preclinical tools for advancing diagnosis and treatment of patients with pancreatic neuroendocrine neoplasms.
Bozena Smolkova, Agapi Kataki, Julie Earl, Ignacio Ruz-Caracuel, Marina Cihova

Crit Rev Oncol Hematol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decitabine potentiates efficacy of doxorubicin in a preclinical trastuzumab-resistant HER2-positive breast cancer models.
Verona Buocikova, Eleonora Marta Longhin, Eleftherios Pilalis, Chara Mastrokalou, Svetlana Miklikova, Marina Cihova

Biomed Pharmacother· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy-triggered changes in stromal compartment drive tumor invasiveness and progression of breast cancer.
Jana Plava, Monika Burikova, Marina Cihova, Lenka Trnkova, Bozena Smolkova

J Exp Clin Cancer Res· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of -Mutated Tumor Microenvironment in Breast Cancer.
Svetlana Miklikova, Lenka Trnkova, Jana Plava, Martin Bohac, Marcela Kuniakova, Marina Cihova

Cancers (Basel)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased levels of circulating cytokines VEGF, TNF-β and IL-15 indicate PD-L1 overexpression in tumours of primary breast cancer patients.
Zuzana Cierna, Bozena Smolkova, Dana Cholujova, Paulina Gronesova, Svetlana Miklikova, Marina Cihova

Sci Rep· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased Stromal Infiltrating Lymphocytes Are Associated with the Risk of Disease Progression in Mesenchymal Circulating Tumor Cell-Positive Primary Breast Cancer Patients.
Bozena Smolkova, Zuzana Cierna, Katarina Kalavska, Svetlana Miklikova, Jana Plava, Marina Cihova

Int J Mol Sci· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammation-Based Scores Increase the Prognostic Value of Circulating Tumor Cells in Primary Breast Cancer.
Svetlana Miklikova, Gabriel Minarik, Tatiana Sedlackova, Jana Plava, Marina Cihova

Cancers (Basel)· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Permanent Pro-Tumorigenic Shift in Adipose Tissue-Derived Mesenchymal Stromal Cells Induced by Breast Malignancy.
Jana Plava, Marina Cihova, Monika Burikova, Martin Bohac, Marian Adamkov

Cells· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A disintegrin and metalloprotease 23 hypermethylation predicts decreased disease-free survival in low-risk breast cancer patients.
Iveta Zmetakova, Lenka Kalinkova, Bozena Smolkova, Viera Horvathova Kajabova, Zuzana Cierna, Marina Cihova

Cancer Sci· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent advances in understanding tumor stroma-mediated chemoresistance in breast cancer.
Jana Plava, Marina Cihova, Monika Burikova, Miroslava Matuskova, Lucia Kucerova

Mol Cancer· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type 3 inositol 1,4,5-trisphosphate receptor has antiapoptotic and proliferative role in cancer cells.
Ingeborg Rezuchova, Sona Hudecova, Andrea Soltysova, Miroslava Matuskova, Erika Durinikova, Marina Cihova

Cell Death Dis· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted antitumor therapy mediated by prodrug-activating mesenchymal stromal cells.
Lucia Kucerova, Erika Durinikova, Lenka Toro, Marina Cihova, Svetlana Miklikova

Cancer Lett· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of mesenchymal stem cells of "no-options" patients with critical limb ischemia treated by autologous bone marrow mononuclear cells.
Cestmir Altaner, Veronika Altanerova, Marina Cihova, Lubica Hunakova, Katarina Kaiserova

PLoS One· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis